Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Bargman

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Surgery, Gynecology & Obstetrics|April 1, 1990
Genital swelling as a surgical complication of continuous ambulatory peritoneal dialysisG Abraham, P G Blake, R E Mathews, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 5, 2002
Local application of mupirocin at the peritoneal catheter exit site prevents early postoperative infections and should become standard practiceK P Prakashan, R A Annigeri, M Chu, et al.
Clinical Nephrology|August 1, 1992
IgA nephritis in HIV-positive patients: a new HIV-associated nephropathy?A Katz, J M Bargman, D C Miller, et al.
Clinical Nephrology|June 10, 2008
Vascular complications of the lower extremities in diabetic patients on peritoneal dialysisT Pliakogiannis, S Bailey, S Cherukuri, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 11, 2002
Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infectionR Annigeri, J Conly, S Vas, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|May 16, 2000
Recurrence of hyperparathyroidism after total parathyroidectomy and autotransplantation in peritoneal dialysis patientsA Zhong, V Billa, L E Rotstein, et al.
International Urology and Nephrology|April 10, 2004
Renal cell carcinoma in peritoneal dialysis patientsS Savaj, V Liakopoulos, S Ghareeb, et al.
Rheumatology (Oxford, England)|January 15, 2009
Acute renal failure in paediatric systemic lupus erythematosus: treatment and outcomeS M Benseler, J M Bargman, B M Feldman, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|November 29, 2002
Prolonged administration over six hours of large doses of intravenous iron saccharate (500 mg) prevents severe adverse reactions in peritoneal dialysis patientsH K Aggarwal, E Tziviskou, V Bellizzi, et al.
Journal of the American Society of Nephrology : JASN|July 30, 1999
Guidelines for adequacy and nutrition in peritoneal dialysis. Canadian Society of NephrologyJ M Bargman, J Bick, P Cartier, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Surgery, Gynecology & Obstetrics|April 1, 1990
Genital swelling as a surgical complication of continuous ambulatory peritoneal dialysisG Abraham, P G Blake, R E Mathews, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 5, 2002
Local application of mupirocin at the peritoneal catheter exit site prevents early postoperative infections and should become standard practiceK P Prakashan, R A Annigeri, M Chu, et al.
Clinical Nephrology|August 1, 1992
IgA nephritis in HIV-positive patients: a new HIV-associated nephropathy?A Katz, J M Bargman, D C Miller, et al.
Clinical Nephrology|June 10, 2008
Vascular complications of the lower extremities in diabetic patients on peritoneal dialysisT Pliakogiannis, S Bailey, S Cherukuri, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 11, 2002
Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infectionR Annigeri, J Conly, S Vas, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|May 16, 2000
Recurrence of hyperparathyroidism after total parathyroidectomy and autotransplantation in peritoneal dialysis patientsA Zhong, V Billa, L E Rotstein, et al.
International Urology and Nephrology|April 10, 2004
Renal cell carcinoma in peritoneal dialysis patientsS Savaj, V Liakopoulos, S Ghareeb, et al.
Rheumatology (Oxford, England)|January 15, 2009
Acute renal failure in paediatric systemic lupus erythematosus: treatment and outcomeS M Benseler, J M Bargman, B M Feldman, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|November 29, 2002
Prolonged administration over six hours of large doses of intravenous iron saccharate (500 mg) prevents severe adverse reactions in peritoneal dialysis patientsH K Aggarwal, E Tziviskou, V Bellizzi, et al.
Journal of the American Society of Nephrology : JASN|July 30, 1999
Guidelines for adequacy and nutrition in peritoneal dialysis. Canadian Society of NephrologyJ M Bargman, J Bick, P Cartier, et al.
Pageof 7